Integrative preclinical strategies for targeting the local mesenchyme as a regulator of tissue specifity in inflammatory musculoskeletal disorders (IMDs)


The consortium MESINFLAME will work across different inflammatory musculoskeletal disorders (IMDs)wird krankheitsübergreifend an chronisch entzündlichen Erkrankungen des muskuloskelettalen Systems (IMDs) and their preclinical models, including rheumatoid arthritis (RA, systemic sclerosis (SSC), granulomatosis with polyangiitis (GPA), idiopathic inflammatory myopathies (IIM), chronic osteomyeltis (cOM) and bone loss in periodontal disease (PD).

our projects


The consortium of MESINFLAME consists of the project coordinator (CO), the project partners, the Steering Committee (SC) and the scientific advisory board (SAB).

the consortia

Projekt partners

Scientists from Münster, Jena, Gießen, Lübeck, Heidelberg, Hamburg an Borstel have joint forces.

the project partners